Allston, MA, United States of America

Michael Figa

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 424(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Figa

Introduction

Michael Figa is a prominent inventor based in Allston, MA (US), known for his significant contributions to the field of drug delivery systems. With a total of nine patents to his name, Figa has made remarkable advancements in the development of therapeutic agents using innovative nanoparticle technology.

Latest Patents

Among his latest patents, Figa has developed drug-loaded polymeric nanoparticles and methods of making and using the same. This patent focuses on methods for creating nanoparticles that contain approximately 0.2 to 35 weight percent of a therapeutic agent, combined with about 10 to 99 weight percent of biocompatible polymers, such as diblock poly(lactic) acid-poly(ethylene) glycol. This innovative approach enhances the efficacy of drug delivery systems, making them more effective in treating various medical conditions.

Career Highlights

Throughout his career, Michael Figa has worked with notable companies in the biotechnology sector, including Bind Therapeutics, Inc. and Bind Biosciences, Inc. His work in these organizations has been instrumental in advancing the field of nanomedicine and improving patient outcomes through innovative drug delivery solutions.

Collaborations

Figa has collaborated with several talented individuals in his field, including Greg Troiano and Abhimanyu Sabnis. These collaborations have fostered a creative environment that has led to groundbreaking advancements in nanoparticle technology.

Conclusion

Michael Figa's contributions to the field of drug delivery through his innovative patents and collaborations highlight his role as a leading inventor in the biotechnology industry. His work continues to pave the way for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…